<DOC>
	<DOC>NCT03039075</DOC>
	<brief_summary>Metformin hydrochloride sustained-release tablets made in Conquer pharmaceutical co., LTD is approved by China Food And Drug Administration (cFDA). Whether its efficacy and safety are equal to Glucophage is unclear.</brief_summary>
	<brief_title>Metformin SR Tablet (DuLeNing) and Glucophage in Patients With Type 2 Diabetes</brief_title>
	<detailed_description>To perform a RCT for the comparison between Metformin hydrochloride sustained-release tablets made in Conquer pharmaceutical co., LTD and Glucophage .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1. Well informed of the procedures of this trial and informed consent is obtained 2. Voluntarily accept standardized treatment 3.1875 years old, gender is not limited 4.Newly diagnosed as type 2 diabetes and have not yet received any hypoglycemic therapy 5.Unable to control the blood glucose by diet and exercise: 7.5% ≤HbA1c ≤11.0%, in screening and before randomization 6.BMI: 19~35 kg/m2 7.Well compliance 8.Capable of self blood Glucose monitoring 1. Pregnant or lactating 2. Type 1 diabetes 3. Poor blood glucose control（HbA1c&gt;11%） 4. A history of malignant tumor 5. Abnormal liver or renal function (defined as alanine aminotransferase(ALT)&gt;2.5 times higher than normal range,or eGFR&lt;45 mL/min per 1•73 m²) 6. Poor blood pressure control [systolic blood pressure(SBP)&gt;180mmHg,or diastolic blood pressure(DBP)&gt;110mmHg] 7. With severe heart disease,cardiac function worse than grade II,anemia(Hb&lt;9.0g/d1) 8. Continuous use of antidiabetic drugs more than one week in recent 3 months 9. History of acute metabolic complications in recent 6 months 10. Blood routine test indicates that the white blood cell count(WBC) &lt;3*109/l 11. Body Mass Index(BMI)&lt;18.5 or ≥35kg/m2 12. Drug or alcohol abuse 13. Accompanying mental disorder who can't collaborate 14. Abnormal digestion and absorption function 15. Other endocrine diseases 16. Other chronic diseases needed longterm glucocorticoid treatment 17. With severe infection, immune dysfunction 18. A history of metformin allergies or allergic constitution</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>